Intraperitoneal α-particle radioimmunotherapy of ovarian cancer patients: pharmacokinetics and dosimetry of 211At-MX35 F (ab′) 2—a phase I study
…, E Cederkrantz, T Bäck, C Divgi… - Journal of Nuclear …, 2009 - Soc Nuclear Med
The α-emitter 211 At labeled to a monoclonal antibody has proven safe and effective in treating
microscopic ovarian cancer in the abdominal cavity of mice. Women in complete clinical …
microscopic ovarian cancer in the abdominal cavity of mice. Women in complete clinical …
Targeted α particle immunotherapy for myeloid leukemia
…, MR McDevitt, RD Finn, CR Divgi… - Blood, The Journal …, 2002 - ashpublications.org
Unlike β particle–emitting isotopes, α emitters can selectively kill individual cancer cells with
a single atomic decay. HuM195, a humanized anti-CD33 monoclonal antibody, specifically …
a single atomic decay. HuM195, a humanized anti-CD33 monoclonal antibody, specifically …
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a …
CR Divgi, N Pandit-Taskar, AA Jungbluth… - The lancet …, 2007 - thelancet.com
Background Preoperative identification of tumour type could have important implications for
the choice of treatment for renal cancers. Antibody cG250 reacts against carbonic anhydrase-…
the choice of treatment for renal cancers. Antibody cG250 reacts against carbonic anhydrase-…
Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts.
S Welt, CR Divgi, AM Scott, P Garin-Chesa… - Journal of clinical …, 1994 - ascopubs.org
PURPOSE To define the toxicity, imaging, and biodistribution characteristics of iodine 131-labeled
monoclonal antibody F19 (131I-mAbF19). MAbF19 recognizes the fibroblast …
monoclonal antibody F19 (131I-mAbF19). MAbF19 recognizes the fibroblast …
Sequential cytarabine and α-particle immunotherapy with bismuth-213–lintuzumab (HuM195) for acute myeloid leukemia
…, DA Mulford, N Pandit-Taskar, CR Divgi… - Clinical cancer …, 2010 - AACR
Purpose: Lintuzumab (HuM195), a humanized anti-CD33 antibody, targets myeloid leukemia
cells and has modest single-agent activity against acute myeloid leukemia (AML). To …
cells and has modest single-agent activity against acute myeloid leukemia (AML). To …
[PDF][PDF] Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250
E Oosterwijk, NH Bander, CR Divgi, S Welt… - Journal of clinical …, 1993 - academia.edu
Purpose: To define the imaging and biodistribution characteristics of iodine 131-labeled
monoclonal antibody (mAb) G250 ('131-mAbG250), which recognizes a cell-surface antigen …
monoclonal antibody (mAb) G250 ('131-mAbG250), which recognizes a cell-surface antigen …
Radiopharmaceutical therapy for palliation of bone pain from osseous metastases
…, M Batraki, CR Divgi - Journal of Nuclear …, 2004 - Soc Nuclear Med
Bone metastasis occurs as a result of a complex pathophysiologic process between host and
tumor cells leading to cellular invasion, migration adhesion, and stimulation of osteoclastic …
tumor cells leading to cellular invasion, migration adhesion, and stimulation of osteoclastic …
The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0
…, A Alavi, HR Balon, SEM Clarke, C Divgi… - Journal of Nuclear …, 2012 - Soc Nuclear Med
THERAPY OF THYROID DISEASE WITH 131I• Silberstein et al. 1633 patients throughout
the United States. Existing practice guidelines will be reviewed for revision or renewal, as …
the United States. Existing practice guidelines will be reviewed for revision or renewal, as …
[HTML][HTML] Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial
CR Divgi, RG Uzzo, C Gatsonis, R Bartz… - Journal of clinical …, 2013 - ncbi.nlm.nih.gov
… The following were principal investigators in the REDECT trial: Chaitanya R. Divgi (coordinating
investigator), Columbia University Medical Center, New York, NY; David Chen, Fox Chase …
investigator), Columbia University Medical Center, New York, NY; David Chen, Fox Chase …
[HTML][HTML] Prolonged red cell storage before transfusion increases extravascular hemolysis
…, M Soffing, R Yeh, C Divgi… - The Journal of …, 2017 - Am Soc Clin Investig
BACKGROUND. Some countries have limited the maximum allowable storage duration for
red cells to 5 weeks before transfusion. In the US, red blood cells can be stored for up to 6 …
red cells to 5 weeks before transfusion. In the US, red blood cells can be stored for up to 6 …